Clinical Trial Update: Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a 13-valent pneumococcal conjugate vaccine in healthy infants has completed, with results posted in 2013. Wyeth is now a wholly owned s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Vaccines, Pneumococcal | Phase 3 | Status: COMPLETED | Results posted: 2013-03-05